SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002405
Filing Date
2022-08-12
Accepted
2022-08-12 16:13:51
Documents
49
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220630x10q.htm   iXBRL 10-Q 1049899
2 EX-31.1 tmb-20220630xex31d1.htm EX-31.1 12887
3 EX-31.2 tmb-20220630xex31d2.htm EX-31.2 12954
4 EX-32.1 tmb-20220630xex32d1.htm EX-32.1 6371
5 EX-32.2 tmb-20220630xex32d2.htm EX-32.2 6418
  Complete submission text file 0001410578-22-002405.txt   4989068

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220630.xsd EX-101.SCH 42075
7 EX-101.CAL tmb-20220630_cal.xml EX-101.CAL 22850
8 EX-101.DEF tmb-20220630_def.xml EX-101.DEF 197078
9 EX-101.LAB tmb-20220630_lab.xml EX-101.LAB 333432
10 EX-101.PRE tmb-20220630_pre.xml EX-101.PRE 275643
43 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220630x10q_htm.xml XML 818065
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40119 | Film No.: 221160226
SIC: 6770 Blank Checks
Office of Real Estate & Construction